Kimberly J. Möller

Kimberly J. Möller

Auto-generated profile, based on publicly available information

Kimberly J. Möller

Research Department of Virus Immunology, Leibniz Institute of Virology (LIV), Hamburg, Germany; These authors contributed equally to this work: Kimberly J. Möller, Lucy H. M. Wegner, Jakob Malsy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2021 in Science Immunology
Verified
Journal Article
Closed access
JJJohannes M. Jung
Johannes M. Jung
WCWilhelm Ching
Wilhelm Ching
MBMartin E. Baumdick
Martin E. Baumdick
HHHelga Hofmann-Sieber
Helga Hofmann-Sieber
JBJens Bernhard Bosse
Jens Bernhard Bosse
MBMadeleine J. Bunders
Madeleine J. Bunders
KIR3DS1 + NK cells execute enhanced killing of adenovirus-infected cells, providing protection against severe infection in immunocompromised hosts.

28 April 2023 in Mucosal Immunology
Verified
Journal Article
Open access
KMKimberly J. Möller
Kimberly J. Möller
LWLucy H.M. Wegner
Lucy H.M. Wegner
JMJakob Malsy
Jakob Malsy
MBMartin E. Baumdick
Martin E. Baumdick
MBMalte Borggrewe
Malte Borggrewe
MBMadeleine J. Bunders
Madeleine J. Bunders
Early life is characterized by extraordinary challenges, including rapid tissue growth and immune adaptation to foreign antigens after birth. During this developmental stage, infants have an increased risk to immune-mediated diseases. Here, we demonstrate that tissue-resident, IL-13 and IL-4-producing ILC2s are enriched in human infant intestines compared to adult intestines. Organoid systems were employed to assess the role of infant intestinal ILC2s in intestinal development and showed that IL-13 and IL-4 increased epithelial cell proliferation and skewed cell differentiation towards secretory cells. IL-13 furthermore upregulated the production of mediators of type-2 immunity by infant intestinal epithelial cells, including VEGF-A and IL-26, a chemoattractant for eosinophils. In line with these in vitro findings increased numbers of eosinophils were detected in vivo in infant intestines. Taken together, ILC2s are enriched in infant intestines and can support intestinal development, while inducing an epithelial secretory response associated with type 2 immune-mediated diseases.

5 January 2023 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
AJAna Jordan-Paiz
Ana Jordan-Paiz
GMGlòria Martrus
Glòria Martrus
FSFenja L. Steinert
Fenja L. Steinert
MKMax Kaufmann
Max Kaufmann
ASAdrian F. Sagebiel
Adrian F. Sagebiel
MBMadeleine J. Bunders
Madeleine J. Bunders